All chemicals were purchased from commercial suppliers and used without further purification. The reactions were performed in an aerobic atmosphere without any specific precautions. Melting points were determined on a Veego melting-point apparatus and were uncorrected. Fourier Transform Infra-Red (FTIR) spectra were recorded within the range of 4000 − 400 cm− 1 using Frontier Perkin-Elmer FTIR SP 10 STD. The 1H and 13C NMR spectra of the synthesized compounds were recorded at 400 and 100 MHz, respectively using Bruker Avance II 400 NMR spectrometer using deuterated chloroform (CDCl3) as the solvent, and the chemical shifts were expressed in parts per million (ppm). Spin multiplicities were described as s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). Mass spectra were recorded on a quadruple-time-of-flight (Q-TOF) mass spectrometer (MICROMASS) using electrospray ionization (ESI) in positive mode. Elemental analyses were performed on Thermo Scientific (Flash 2000) CHN Elemental Analyzer. Thin-layer chromatography (TLC) was carried out using pre-coated aluminium sheets with silica gel-60 F254.
2.1. General procedure for synthesis of 2-(4-(1-isonicotinoyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)) derivatives (3a-f)
Pertinent N-phenylacetamide derivatives (1a-o, 1 mmol) [21] and isoniazid (0.165g, 1.2 mmol) were taken in a 50 c.c. round-bottomed flask containing 5 mL of acetic acid. The mixture was refluxed and the progress was monitored by TLC (petroleum ether: ethyl acetate in 3:2). After completion of the reaction ice-cold water was added, precipitate obtained was washed with water and then with acetone to obtain a solid product in pure form.
2.1.1. 2-(4-(1-Isonicotinoyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)-N-phenylacetamide (3a)
Prepared from (E)-2-(4-cinnamoylphenoxy)-N-phenylacetamide (1a, 0.357g, 1 mmol); light yellow powder; Yield: 82%; m.p. 74–76°C; FTIR (ῡ, cm− 1) 3168 (N-H), 3098 (C-H, sp2), 2978, 2856 (C-H, sp3), 1662 (NH-C = O), 1648 (C = N), 1566, 1495 (C…C, ring str.), 1466 (CH2, bend), 1345 (C-N, ring), 1220 (C-O-C), 850, 745 (sub. Phenyl, sp2 C-H bend); 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, 2H, J = 8 Hz, H-32,34, Ring D), 8.21 (d, 2H, J = 12 Hz, H-14,16, Ring A), 8.09 (d, 2H, J = 8 Hz, H-31,35, Ring D), 7.70–7.63 (m, 2H, H-6,10, Ring C), 7.59–7.53 (m, 2H, H-24,28, Ring B), 7.35–7.28 (m, 6H, Ring B & C), 7.05 (d, 2H, J = 12 Hz, H-13,17, Ring A), 5.80 (dd, 1H, H-22, Ring E), 4.70 (s, 2H, CH2), 3.75 (dd, 1H, H-21, Ring E), 3.19 (dd, 1H, H-21’, Ring E); 13C NMR (100 MHz, DMSO-d6) δ 167.8, 167.1, 160.6, 151.9, 149.4, 141.9, 140.8, 138.7, 129.1, 128.5, 128.8, 128.1, 126.8, 126.6, 121.8, 121.5, 114.5, 66.8, 66.5, 40.1; HRMS m/z [M + H]+: 477.54; Anal. Calcd. for C29H24N4O3: C, 73.09, H, 5.08, N, 11.76. Found C, 73.11, H, 5.09, N, 11.79.
2.1.2. N-(4-fluorophenyl)-2-(4-(1-isonicotinoyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)acetamide (3b)
Prepared from (E)-2-(4-cinnamoylphenoxy)-N-(4-fluorophenyl)acetamide (1b, 0.375g, 1 mmol); light yellow powder; Yield: 84%; m.p. 138–140°C; FTIR (ῡ, cm− 1) 3411 (N-H), 3098 (C-H, sp2), 2978, 2856 (C-H, sp3), 1674 (NH-C = O), 1658 (C = N), 1566, 1495 (C…C, ring str.), 1446 (CH2, bend), 1345 (C-N, ring), 1232 (C-O-C), 850, 745 (sub. Phenyl, sp2 C-H bend); 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, 2H, J = 12 Hz, H-32,34, Ring D), 8.53 (s, 1H, NH), 8.25 (d, 2H, J = 8 Hz, H-14,16, Ring A), 7.84–7.78 (m, 4H, Ring B & C) 7.71 (d, 2H, J = 12Hz, H-31,35, Ring D), 7.35–7.30 (m, 5H, Ring B & C), 7.04 (d, 2H, J = 8Hz, H-13,17, Ring A), 5.81 (dd, 1H, H-22, Ring E), 4.68 (s, 2H, CH2), 3.83 (dd, 1H, H-21, Ring E), 3.25 (dd, 1H, H-21’, Ring E); 13C NMR (100 MHz, DMSO-d6) δ 167.9, 167.2, 162.7, 160.3, 151.8, 149.4, 141.0, 140.6, 134.3, 128.8, 128.5, 126.8, 126.6, 121.6, 120.5, 115.1, 114.3, 66.8, 66.6, 40.3; HRMS m/z [M + H]+: 495.24; Anal. Calcd. for C29H23FN4O3: C, 70.43, H, 4.69, N, 11.33. Found C, 70.41, H, 4.65, N, 11.36.
2.1.3. 2-(4-(1-isonicotinoyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)-N-(p-tolyl)acetamide (3c)
Prepared from (E)-2-(4-cinnamoylphenoxy)-N-(p-tolyl)acetamide (1c, 0.371g, 1 mmol); off white powder; Yield: 84%; m.p. 124–126°C; FTIR (ῡ, cm− 1) 3275 (N-H), 3072 (C-H, sp2), 2961, 2859 (C-H, sp3), 1672 (NH-C = O), 1652 (C = N), 1567, 1495 (C…C, ring str.), 1451 (CH2, bend), 1376 (C-N, ring), 1270 (C-O-C), 928, 838, 762 (sub. Phenyl, sp2 C-H bend); 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, 2H, J = 8 Hz, H-32,34, Ring D), 8.10 (d, 2H, J = 12 Hz, H-14,16, Ring A), 7.82 (d, 2H, J = 8 Hz, H-31,35, Ring D), 7.47–7.41 (m, 4H, Ring C), 7.24–7.17 (m, 5H, Ring B), 7.04–7.01 (d, 2H, J = 12 Hz, H-13,17, Ring A), 5.78 (dd, 1H, H-22, Ring E), 4.69 (s, 2H, CH2), 3.83 (dd, 1H, H-21, Ring E), 3.25 (dd, 1H, H-21’, Ring E); 13C NMR (100 MHz, DMSO-d6) δ 167.7, 167.3, 160.2, 151.6, 149.8, 141.8, 140.7, 136.7, 135.3, 129.3, 128.8, 128.5, 126.9, 126.6, 121.8, 121.6, 114.5, 66.8, 66.5, 39.7, 21.2; HRMS m/z [M + H]+: 491.51; Anal. Calcd. for C30H26N4O3: C, 73.45, H, 5.34, N, 11.42. Found C, 73.41, H, 5.36, N, 11.39.
2.1.4. 2-(4-(1-isonicotinoyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)-N-(4-methoxyphenyl)acetamide (3d)
Prepared from (E)-2-(4-cinnamoylphenoxy)-N-(4-methoxyphenyl)acetamide (1d, 0.387g, 1 mmol); yellow powder; Yield: 84%; m.p. 158–160°C; FTIR (ῡ, cm− 1) 3238 (N-H), 3082 (C-H, sp2), 2946, 2861 (C-H, sp3), 1669 (NH-C = O), 1651 (C = N), 1579, 1495 (C…C, ring str.), 1442 (CH2, bend), 1368 (C-N, ring), 1268 (C-O-C), 928, 774 (sub. Phenyl, sp2 C-H bend); 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, 2H, J = 12 Hz, H-32,34, Ring D), 8.16 (d, 2H, J = 16 Hz, H-14,16, Ring A), 7.99 (d, 2H, J = 12 Hz, H-31,35, Ring D), 7.47–7.41 (m, 4H, Ring B & C), 7.10–7.03 (m, 3H, Ring B), 6.97 (d, 2H, J = 16 Hz, H-13,17, Ring A), 6.81–6.77 (m, 2H, Ring C), 5.77 (dd, 1H, H-22, Ring E), 4.64 (s, 2H, CH2), 3.75–3.70 (m, 4H, OCH3 & H-21, Ring E) 3.19 (dd, 1H, H-21’, Ring E); 13C NMR (100 MHz, DMSO-d6) δ 167.6, 167.1, 160.6, 158.9, 151.5, 149.7, 141.5, 140.8, 130.9, 128.7, 128.6, 126.7, 126.4, 122.6, 121.7, 114.6, 114.1, 66.9, 66.5, 55.8, 39.9; HRMS m/z [M + H]+: 507.53; Anal. Calcd. for C30H26N4O4: C, 71.13, H, 5.17, N, 11.06. Found C, 71.15, H, 5.19, N, 11.09.
2.1.5. N-(4-bromophenyl)-2-(4-(1-isonicotinoyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)acetamide (3e)
Prepared from (E)-N-(4-bromophenyl)-2-(4-cinnamoylphenoxy)acetamide (1e, 0.436g, 1 mmol); off white powder; Yield: 86%; m.p. 140–142°C; FTIR (ῡ, cm− 1) 3334 (N-H), 3102 (C-H, sp2), 2976, 2867 (C-H, sp3), 1671 (NH-C = O), 1652 (C = N), 1591, 1487 (C…C, ring str.), 1457 (CH2, bend), 1357 (C-N, ring), 1235 (C-O-C), 898, 756 (sub. Phenyl, sp2 C-H bend); 1H NMR (400 MHz, DMSO-d6) δ 8.88 (d, 2H, J = 12 Hz, H-32,34, Ring D), 8.12 (d, 2H, J = 8 Hz, H-14,16, Ring A), 7.81 (d, 2H, J = 12 Hz, H-31,35, Ring D), 7.65–7.61 (m, 2H, H-6,10, Ring C), 7.28–7.23 (m, 5H, Ring B), 6.85–6.80 (m, 4H, Ring A & C), 5.78 (dd, 1H, H-22, Ring E), 4.72 (s, 2H, CH2), 3.79 (dd, 1H, H-21, Ring E), 3.24 (dd, 1H, H-21’, Ring E); 13C NMR (100 MHz, DMSO-d6) δ 167.9, 167.2, 161.1, 152.2, 149.8, 141.6, 140.6, 137.6, 131.7, 129.3, 128.6, 128.5, 126.8, 126.5, 121.7, 122.5, 114.5, 66.7, 66.5, 39.8; HRMS m/z [M + H]+: 556.45; Anal. Calcd. for C29H23BrN4O3: C, 62.71, H, 4.17, N, 10.09. Found C, 62.74, H, 4.19, N, 10.05.
2.1.6. N-(4-chlorophenyl)-2-(4-(1-isonicotinoyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy)acetamide (3f)
Prepared from (E)-N-(4-chlorophenyl)-2-(4-cinnamoylphenoxy)acetamide (1f, 0.391g, 1 mmol); off white powder; Yield: 84%; m.p. 120–122°C; FTIR (ῡ, cm− 1) 3297 (N-H), 3084 (C-H, sp2), 2946, 2854 (C-H, sp3), 1667 (NH-C = O), 1655 (C = N), 1597, 1494 (C…C, ring str.), 1461 (CH2, bend), 1369 (C-N, ring), 1257 (C-O-C), 945, 686 (sub. Phenyl, sp2 C-H bend); 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, 2H, J = 12 Hz, H-32,34, Ring D), 8.09 (d, 2H, J = 8 Hz, H-14,16, Ring A), 7.85 (d, 2H, J = 12 Hz, H-31,35, Ring D), 7.67–7.63 (m, 2H, H-6,10, Ring C), 7.30–7.35 (m, 5H, Ring B), 6.89–6.84 (m, 4H, Ring A & C), 5.80 (dd, 1H, H-22, Ring E), 4.69 (s, 2H, CH2), 3.85 (dd, 1H, H-21, Ring E), 3.28 (dd, 1H, H-21’, Ring E); 13C NMR (100 MHz, DMSO-d6) δ 167.8, 167.3, 160.5, 151.7, 149.7, 141.5, 140.9, 136.5, 133.4, 129.3, 128.6, 128.5, 126.8, 126.5, 121.5, 120.5, 114.5, 66.7, 66.5, 39.8; HRMS m/z [M + H]+: 511.95; Anal. Calcd. for C29H23ClN4O3: C, 68.17, H, 4.54, N, 10.96. Found C, 68.19, H, 4.57, N, 10.94.